相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defining new surrogate markers for CKD progression
H. William Schnaper et al.
PEDIATRIC NEPHROLOGY (2015)
Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)
Hiddo J. Lambers Heerspink et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
GFR Decline as an End Point in Trials of CKD: A Viewpoint From the FDA
Aliza Thompson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials
Hiddo J. Lambers Heerspink et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials
Lesley A. Inker et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Effect of Pravastatin on Total Kidney Volume, Left Ventricular Mass Index, and Microalbuminuria in Pediatric Autosomal Dominant Polycystic Kidney Disease
Melissa A. Cadnapaphornchai et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Net Reclassification Indices for Evaluating Risk Prediction Instruments A Critical Review
Kathleen F. Kerr et al.
EPIDEMIOLOGY (2014)
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
Josef Coresh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease
Ismail Kocyigit et al.
JOURNAL OF NEPHROLOGY (2014)
Predictors of Autosomal Dominant Polycystic Kidney Disease Progression
Robert W. Schrier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Cell cycle arrest biomarkers win race for AKI diagnosis
Zoltan H. Endre et al.
NATURE REVIEWS NEPHROLOGY (2014)
Biomarkers in Acute Kidney Injury: Are We Ready for Prime Time?
Prasad Devarajan et al.
NEPHRON CLINICAL PRACTICE (2014)
Clinical Trial Endpoints in Acute Kidney Injury
Frederic T. Billings et al.
NEPHRON CLINICAL PRACTICE (2014)
A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index
Jorgen Hilden et al.
STATISTICS IN MEDICINE (2014)
Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status
Anja Haase-Fielitz et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Relationship of Copeptin, a Surrogate Marker for Arginine Vasopressin, With Change in Total Kidney Volume and GFR Decline in Autosomal Dominant Polycystic Kidney Disease: Results From the CRISP Cohort
Wendy E. Boertien et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
Andreas D. Kistler et al.
PLOS ONE (2013)
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kianoush Kashani et al.
CRITICAL CARE (2013)
Emergent Early Markers of Renal Progression in Autosomal-Dominant Polycystic Kidney Disease Patients: Implications for Prevention and Treatment
Imed Helal et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
Arlene B. Chapman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Microalbuminuria as Surrogate Endpoint in Therapeutic Trials
Josep Redon et al.
CURRENT HYPERTENSION REPORTS (2012)
Proteinuria as a surrogate end point-more data are needed
Aliza Thompson
NATURE REVIEWS NEPHROLOGY (2012)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Biomarkers and surrogate endpoints in clinical trials
Thomas R. Fleming et al.
STATISTICS IN MEDICINE (2012)
Evaluating the Incremental Value of New Biomarkers With Integrated Discrimination Improvement
Kathleen F. Kerr et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?
Richard J. Glassock
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?
Hiddo J. Lambers Heerspink et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Ravindra L. Mehta et al.
CRITICAL CARE (2007)
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease
Vicente E. Torres et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validation
Tomasz Burzykowski et al.
PHARMACEUTICAL STATISTICS (2006)
Volume progression in polycystic kidney disease
JJ Grantham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Statistical evaluation of biomarkers as surrogate endpoints: a literature review
CJ Weir et al.
STATISTICS IN MEDICINE (2006)
Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease
H Wong et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
The number, quality, and coverage of randomized controlled trials in nephrology
GFM Strippoli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Statins induce the regression of left ventricular mass in patients with angina
H Nishikawa et al.
CIRCULATION JOURNAL (2004)
Prentice's approach and the meta-analytic paradigm: A reflection on the role of statistics in the evaluation of surrogate endpoints
A Alonso et al.
BIOMETRICS (2004)
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
AB Chapman et al.
KIDNEY INTERNATIONAL (2003)
Beyond lipid-lowering: effects of statins on endothelial nitric oxide
U Laufs
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop
VG De Gruttola et al.
CONTROLLED CLINICAL TRIALS (2001)
分享论文
